1887

Journal of General Virology header logo

Volume 83, Issue 7

PTEN is a negative regulator of STAT3 activation in human papillomavirus-infected cells Free

Abstract

Laryngeal papillomas are caused by infection of the laryngeal epithelium by human papillomavirus type 6 or type 11 (HPV-6/-11). Previous studies in our laboratory have demonstrated an increase in PI3 kinase levels in papilloma tissue. However, activation of the downstream effector of PI3 kinase, protein kinase B (PKB/Akt), was reduced. This observation was explained by the elevated expression of the phosphatase and tensin homologue (PTEN), a recently characterized tumour suppressor, in papilloma tissue. Recent investigation of the possible functional roles of PTEN during papilloma development has now indicated that the level of tyrosine(705)-phosphorylated signal transducer and activator of transcription 3 [PTyr(705)STAT3] could be inversely correlated to that of PTEN as well. phosphatase assays suggested the presence of an increased level of a PTyr(705)STAT3 phosphatase in papilloma extract. Immunodepletion of PTEN from papilloma extracts resulted in a reduction of the PTyr(705)STAT3 phosphatase activity. Transfection of PTEN cDNA into HeLa cells attenuated STAT3 phosphorylation at Tyr(705) in a dose-dependent manner. This attenuation of STAT3 phosphorylation was independent of the STAT3 kinase. Interestingly, introduction of a lipid phosphatase mutant of PTEN (G129E) resulted in heightened PTyr(705)STAT3 phosphatase activity, relative to that obtained from wild-type PTEN transfection. These data indicate that PTEN negatively regulates STAT3 activation in HPV-infected papilloma cells. Induction of PTEN and reduction of activated STAT3 might be a result of a host defence mechanism or a virus-directed strategy to alter normal epithelial differentiation programming.

  • Received:
  • Accepted:
  • Published Online:
© Microbiology Society
Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-83-7-1651
2002-07-01
2024-04-25
Loading full text...

Full text loading...

/deliver/fulltext/jgv/83/7/0831651a.html?itemId=/content/journal/jgv/10.1099/0022-1317-83-7-1651&mimeType=html&fmt=ahah

References

  1. Barkett M., Gilmore T. D. 1999; Control of apoptosis by Rel/NF-kappaB transcription factors. Oncogene 18:6910–6924
     [Google Scholar]
  2. Bromberg J. F., Wrzeszczynska M. H., Devgan G., Zhao Y., Pestell R. G., Albanese C., Darnell J. E. Jr 1999; Stat3 as an oncogene. Cell 98:295–303 [published erratum appears in Cell 99, 239]
    [Google Scholar]
  3. Brunet A., Bonni A., Zigmond M. J., Lin M. Z., Juo P., Hu L. S., Anderson M. J., Arden K. C., Blenis J., Greenberg M. E. 1999; Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 96:857–868
     [Google Scholar]
  4. Cairns P., Okami K., Halachmi S., Halachmi N., Esteller M., Herman J. G., Jen J., Isaacs W. B., Bova G. S., Sidransky D. 1997; Frequent inactivation of PTEN/MMAC1 in primary prostate cancer. Cancer Research 57:4997–5000
     [Google Scholar]
  5. Cantley L. C., Neel B. G. 1999; New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway. Proceedings of the National Academy of Sciences, USA 96:4240–4245
     [Google Scholar]
  6. Cao X., Tay A., Guy G. R., Tan Y. H. 1996; Activation and association of Stat3 with Src in v-Src-transformed cell lines. Molecular and Cellular Biology 16:1595–1603
     [Google Scholar]
  7. Cheney I. W., Neuteboom S. T., Vaillancourt M. T., Ramachandra M., Bookstein R. 1999; Adenovirus-mediated gene transfer of MMAC1/PTEN to glioblastoma cells inhibits S phase entry by the recruitment of p27Kip1 into cyclin E/CDK2 complexes. Cancer Research 59:2318–2323
     [Google Scholar]
  8. Flores E. R., Lambert P. F. 1997; Evidence for a switch in the mode of human papillomavirus type 16 DNA replication during the viral life cycle. Journal of Virology 71:7167–7179
     [Google Scholar]
  9. Fukada T., Hibi M., Yamanaka Y., Takahashi-Tezuka M., Fujitani Y., Yamaguchi T., Nakajima K., Hirano T. 1996; Two signals are necessary for cell proliferation induced by a cytokine receptor gp 130: involvement of STAT3 in anti-apoptosis. Immunity 5:449–460
     [Google Scholar]
  10. Ghosh A. K., Grigorieva I., Steele R., Hoover R. G., Ray R. B. 1999; PTEN transcriptionally modulates c-myc gene expression in human breast carcinoma cells and is involved in cell growth regulation. Gene 235:85–91
     [Google Scholar]
  11. Grandis J. R., Drenning S. D., Chakraborty A., Zhou M. Y., Zeng Q., Pitt A. S., Tweardy D. J. 1998; Requirement of Stat3 but not Stat1 activation for epidermal growth factor receptor-mediated cell growth in vitro. Journal of Clinical Investigation 102:1385–1392
     [Google Scholar]
  12. Grandis J. R., Drenning S. D., Zeng Q., Watkins S. C., Melhem M. F., Endo S., Johnson D. E., Huang L., He Y., Kim J. D. 2000; Constitutive activation of Stat3 signaling abrogates apoptosis in squamous cell carcinogenesis in vivo. Proceedings of the National Academy of Sciences, USA 97:4227–4232
     [Google Scholar]
  13. Gu J., Tamura M., Pankov R., Danen E. H., Takino T., Matsumoto K., Yamada K. M. 1999; Shc and FAK differentially regulate cell motility and directionality modulated by PTEN. Journal of Cell Biology 146:389–403
     [Google Scholar]
  14. Guttridge D. C., Albanese C., Reuther J. Y., Pestell R. G., Baldwin Baldwin. A. Jr 1999; NF-kappaB controls cell growth and differentiation through transcriptional regulation of cyclin D1. Molecular and Cellular Biology 19:5785–5799
     [Google Scholar]
  15. Johnston D., Hall H., DiLorenzo T. P., Steinberg B. M. 1999; Elevation of the epidermal growth factor receptor and dependent signaling in human papillomavirus-infected laryngeal papillomas. Cancer Research 59:968–974
     [Google Scholar]
  16. Kaltschmidt B., Kaltschmidt C., Hehner S. P., Droge W., Schmitz M. L. 1999; Repression of NF-kappaB impairs HeLa cell proliferation by functional interference with cell cycle checkpoint regulators. Oncogene 18:3213–3225
     [Google Scholar]
  17. Lee J. O., Yang H., Georgescu M. M., Di Cristofano A., Maehama T., Shi Y., Dixon J. E., Pandolfi P., Pavletich N. P. 1999; Crystal structure of the PTEN tumor suppressor: implications for its phosphoinositide phosphatase activity and membrane association. Cell 99:323–334
     [Google Scholar]
  18. Li D. M., Sun H. 1997; TEP 1, encoded by a candidate tumor suppressor locus, is a novel protein tyrosine phosphatase regulated by transforming growth factor beta. Cancer Research 57:2124–2129
     [Google Scholar]
  19. Li J., Yen C., Liaw D., Podsypanina K., Bose S., Wang S. I., Puc J., Miliaresis C., Rodgers L., McCombie R., Bigner S. H., Giovanella B. C., Ittmann M., Tycko B., Mbshoosh H., Wigler M. H., Parsons R. 1997; PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer (see comments). Science 275:1943–1947
     [Google Scholar]
  20. Liu W., James C. D., Frederick L., Alderete B. E., Jenkins R. B. 1997; PTEN/MMAC I mutations and EG-FR amplification in glioblastomas. Cancer Research 57:5254–5257
     [Google Scholar]
  21. Maehama T., Dixon J. E. 1998; The tumor suppressor, PTEN/MMAC 1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate. Journal of Biological Chemistry 273:13375–13378
     [Google Scholar]
  22. Mayo M. W., Baldwin A. S. 2000; The transcription factor NF-kappaB: control of oncogenesis and cancer therapy resistance. Biochimica et Biophysica Acta 1470:M55–62
     [Google Scholar]
  23. Medema R. H., Kops G. J., Bos J. L., Burgering B. M. 2000; AFX-like Forkhead transcription factors mediate cell-cycle regulation by Ras and PKB through p27kip1. Nature 404:782–787
     [Google Scholar]
  24. Myers M. P., Stolarov J. P., Eng C., Li J., Wang S. I., Wigler M. H., Parsons R., Tonks N. K. 1997; P-TEN, the tumor suppressor from human chromosome l0q23, is a dual-specificity phosphatase. Proceedings of the National Academy of Sciences, USA 94:9052–9057
     [Google Scholar]
  25. Myers M. P., Pass I., Batty I. H., van der Kaay J., Stolarov J. P., Hemmings B. A., Wigler M. H., Downes C. P., Tonks N. K. 1998; The lipid phosphatase activity of PTEN is critical for its tumor supressor function. Proceedings of the National Academy of Sciences, USA 95:13513–13518
     [Google Scholar]
  26. Nelen M. R., van Staveren W. C., Peeters E. A., Hassel M. B., Gorlin R. J., Hamm H., Lindboe C. F., Fryns J. P., Sijmons R. H., Woods D. G., Mariman E. C., Padberg G. W., Kremer H. 1997; Germline mutations in the PTEN/MXIAC I gene in patients with Cowden disease. Human Molecular Genetics 6:1383–1387
     [Google Scholar]
  27. Nelson K. L., Rogers J. A., Bowman T. L., Jove R., Smithgall T. E. 1998; Activation of STAT3 by the c-Fes protein-tyrosine kinase. Journal of Biological Chemistry 273:7072–7077
     [Google Scholar]
  28. Ni Z., Lou W., Leman E. S., Gao A. C. 2000; Inhibition of constitutively activated Stat3 signaling pathway suppresses growth of prostate cancer cells. Cancer Research 60:1225–1228
     [Google Scholar]
  29. Ozes O. N., Mayo L. D., Gustin J. A., Pfeffer S. R., Pfeffer L. M., Donner D. B. 1999; NF-kappaB activation by tumour necrosis factor requires the Akt serinethreonine kinase (see comments). Nature 401:82–85
     [Google Scholar]
  30. Paramio J. M., Navarro M., Segrelles C., Gomez-Casero E., Jorcano J. L. 1999; PTEN tumour suppressor is linked to the cell cycle control through the retinoblastoma protein. Oncogene 18:7462–7468
     [Google Scholar]
  31. Risinger J. I., Hayes A. K., Berchuck A., Barrett J. C. 1997; PTEN/MMAAC1 mutations in endometrial cancers. Cancer Research 57:4736–4738
     [Google Scholar]
  32. Romashkova J. A., Makarov S. S. 1999; NF-kappaB is a target of AKT in antiapoptotic PDGF signalling (see comments). Nature 401:86–90
     [Google Scholar]
  33. Schaefer L. K., Wang S., Schaefer T. S. 1999; c-Src activates the DNA binding and transcriptional activity of Stat3 molecules: serine 727 is not required for transcriptional activation under certain circumstances. Biochemical and Biophysical Research Communications 266:481–487
     [Google Scholar]
  34. Steck P. A., Pershouse M. A., Jasser S. A., Yung W. K., Lin H., Ligon A. H., Langford L. A., Baumgard M. L., Hattier T., Davis T., Frye C., Hu R., Swedlund B., Teng D. H., Tavtigian S. V. 1997; Identification of a candidate tumour suppressor gene, MMAC 1, at chromosome 10q23·3 that is mutated in multiple advanced cancers. Nature Genetics 15:356–362
     [Google Scholar]
  35. Steinberg B. M., Meade R., Kalinowski S., Abramson A. L. 1990; Abnormal differentiation of human papillomavirus-induced laryngeal papillomas. Archives of Otolaryngology – Head and Neck Surgery 116:1167–1171
     [Google Scholar]
  36. Stoler M. H., Wolinsky S. M., Whitbeck A., Broker T. R., Chow L. T. 1989; Differentiation-linked human papillomavirus types 6 and 11 transcription in genital condylomata revealed by in situ hybridization with message-specific RNA probes. Virology 172:331–340
     [Google Scholar]
  37. Takeda K., Kaisho T., Yoshida N., Takeda J., Kishimoto T., Akira S. 1998; Stat3 activation is responsible for IL-6-dependent T cell proliferation through preventing apoptosis: generation and characterization of T cell-specific Stat3-deficient mice. Journal of Immunology 161:4652–4660
     [Google Scholar]
  38. Tamura M., Gu J., Matsumoto K., Aota S., Parsons R., Yamada K. M. 1998; Inhibition of cell migration, spreading, and focal adhesions by tumor suppressor PTEN. Science 280:1614–1617
     [Google Scholar]
  39. Tamura M., Gu J., Takino T., Yamada K. M. 1999; Tumor suppressor PTEN inhibition of cell invasion, migration, and growth: differential involvement of focal adhesion kinase and p130Cas. Cancer Research 59:442–449
     [Google Scholar]
  40. Teng D. H., Hu R., Lin H., Davis T., Iliev D., Frye C., Swedlund B., Hansen K. L., Vinson V. L., Gumpper K. L., Ellis L., El-Naggar A., Frazier M., Jasser S., Langford L. A., Lee J., Mills G. B., Pershouse M. A., Pollack R. E., Tornos C., Troncoso P., Yung W. K., Fujii G., Berson A., Steck P. A. 1997; MMAC1/PTEN mutations in primary tumor specimens and tumor cell lines. Cancer Research 57:5221–5225
     [Google Scholar]
  41. Vambutas A., Di Lorenzo T. P., Steinberg B. M. 1993; Laryngeal papilloma cells have high levels of epidermal growth factor receptor and respond to epidermal growth factor by a decrease in epithelial differentiation. Cancer Research 53:910–914
     [Google Scholar]
  42. Vancurova I., Wu R., Miskolci V., Sun S. 2002; Increased p50/p50 NF-kappaB activation in human papillomavirus type 6- or type 11-induced laryngeal papilloma tissue. Journal of Virology 76:1533–1536
     [Google Scholar]
  43. Wu X., Hepner K., Castelino-Prabhu S., Do D., Kaye M. B., Yuan X. J., Wood J., Ross C., Sawyers C. L., Whang Y. E. 2000a; Evidence for regulation of the PTEN tumor suppressor by a membrane-localized multi-PDZ domain containing scaffold protein MAGI-2. Proceedings of the National Academy of Sciences, USA 97:4233–4238
     [Google Scholar]
  44. Wu Y., Dowbenko D., Spencer S., Laura R., Lee J., Gu Q., Lasky L. A. 2000b; Interaction of the tumor suppressor PTEN/MMAC with a PDZ domain of MAGI3, a novel membrane-associated guanylate kinase. Journal of Biological Chemistry 275:21477–21485
     [Google Scholar]
  45. Zhang P., Steinberg B. M. 2000; Overexpression of PTEN/MMAC1 and decreased activation of Akt in human papillomavirus-infected laryngeal papillomas. Cancer Research 60:1457–1462
     [Google Scholar]
  46. Zhong Z., Wen Z., Darnell Darnell. J. Jr 1994; Stat3: a STAT family member activated by tyrosine phosphorylation in response to epidermal growth factor and interleukin-6. Science 264:95–98
     [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-83-7-1651
Loading
PTEN is a negative regulator of STAT3 activation in human papillomavirus-infected cells
J. Gen. Virol. 83, 1651 (2002); https://doi.org/10.1099/0022-1317-83-7-1651
/content/journal/jgv/10.1099/0022-1317-83-7-1651
/content/journal/jgv/10.1099/0022-1317-83-7-1651
Loading

Data & Media loading...

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error